Collaborative Drug

MAY 18, 2024

Upcoming Webinar: Targeted Protein Degradation - New Modalities and Design Technologies

Targeted Protein Degradation 275

Targeted Protein Degradation 275

Drugs.com

MAY 18, 2024

SATURDAY, May 18, 2024 -- People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose, congestion and itchy eyes, nose or throat.But they often aren’t aware that.

147

147

Drug Patent Watch

MAY 18, 2024

ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.

Pharmaceuticals 64

Pharmaceuticals Drugs 64

Drug Patent Watch

MAY 18, 2024

This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Drug Patent Watch

MAY 18, 2024

Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier.

Drugs 59

Drugs Marketing 59